drugset / Trial / NCT00040521
Study Evaluating rhIL-11 in Active Crohn's Disease
RandomizedDouble-blindTreatment
Summary
The purpose of this study is to assess the activity of multiple doses of oral rhIL-11 in patients with active Crohn's disease (Crohn's Disease Activity Index \[CDAI\] score from 220-400).
Timeline
- Start
- 2002-04
- Primary completion
- 2003-10
- Completion
- 2003-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Interleukin-11 | Protein / enzyme biologic | — | Oral |